RT Journal Article
SR Electronic
T1 How many lives can be saved? A global view on the impact of testing, herd immunity and demographics on COVID-19 fatality rates
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.29.20084400
DO 10.1101/2020.04.29.20084400
A1 Miguel Sánchez-Romero
A1 Vanessa di Lego
A1 Alexia Prskawetz
A1 Bernardo L Queiroz
YR 2020
UL http://medrxiv.org/content/early/2020/05/05/2020.04.29.20084400.abstract
AB In this work, we assess the global impact of COVID-19 showing how demographic factors, testing policies and herd immunity are key for saving lives. We extend a standard epidemiological SEIR model in order to: (a) identify the role of demographics (population size and population age distribution) on COVID-19 fatality rates; (b) quantify the maximum number of lives that can be saved according to different testing strategies, different levels of herd immunity, and specific population characteristics; and (d) infer from the observed case fatality rates (CFR) what the true fatality rate might be. Different from previous SEIR model extensions, we implement a Bayesian Melding method in our calibration strategy which enables us to account for data limitation on the total number of deaths. We derive a distribution of the set of parameters that best replicate the observed evolution of deaths by using information from both the model and the data.One Sentence Summary Demographics factors, testing policies and herd immunity are key for quantifying the maximum number of lives that can be saved from COVID-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementAll authors state that they have not received any funding for supporting this research.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is available in the main text or the supplementary materials, as well as in the github repository sent together with this submission. All data used in this study is public. https://github.com/vdilego/COVID-19_SEIR_Bayesian_Melding